Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents

NCT05953389 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: Pitolisant
DRUG: Placebo

Sponsor

Bioprojet